The increase in CPT1A expressions observed in grade 2 and grade 3 pancreatic cancer was statistically significant; indeed, there was an up to 4-fold increase in the H-score between grade 3 cancer and normal tissue. This evidence concerns the gene CPT1A and familial pancreatic carcinoma.